Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 1;27(9):e202301283.
doi: 10.1002/ejoc.202301283. Epub 2024 Jan 15.

Fun With Unusual Functional Groups: Sulfamates, Phosphoramidates, and Di-tert-butyl Silanols

Affiliations

Fun With Unusual Functional Groups: Sulfamates, Phosphoramidates, and Di-tert-butyl Silanols

Shyam Sathyamoorthi. European J Org Chem. .

Abstract

Compared to ubiquitous functional groups such as alcohols, carboxylic acids, amines, and amides, which serve as central "actors" in most organic reactions, sulfamates, phosphoramidates, and di-tert-butyl silanols have historically been viewed as "extras". Largely considered functional group curiosities rather than launch-points of vital reactivity, the chemistry of these moieties is under-developed. Our research program has uncovered new facets of reactivity of each of these functional groups, and we are optimistic that the chemistry of these fascinating molecules can be developed into truly general transformations, useful for chemists across multiple disciplines. In the ensuing sections, I will describe our efforts to develop new reactions with these "unusual" functional groups, namely sulfamates, phosphoramidates, and di-tert-butyl silanols.

Keywords: alkene functionalization; aza-Wacker; organic methodology; silanol; total synthesis.

PubMed Disclaimer

Figures

Scheme 1.
Scheme 1.
Classical and tethered aza-Wacker cyclization reactions at the time of our laboratory’s entry into the field.
Scheme 2.
Scheme 2.
Sulfamate-tethered aza-Wacker cyclization reactions give alkenyl oxathiazinane products, which are allylic amine surrogates.
Scheme 3.
Scheme 3.
Our progress towards bactobolin A.
Scheme 4.
Scheme 4.
Application of our sulfamate-tethered aza-Wacker cyclization to the preparation of orthogonally protected D-galactosamines.
Scheme 5.
Scheme 5.
Application of our sulfamate-tethered aza-Wacker cyclization to the preparation of a kasugamine synthon.
Scheme 6.
Scheme 6.
An unusual 5-chloro-8-hydroxyquinoline arm allows for complete diastereocontrol in our phosphoramidate tethered aza-Wacker cyclization.
Scheme 7.
Scheme 7.
Conversion of cyclic phosphoramidates into (A) 1,3-chloroamines and (B) 1,3-aminoalcohols.
Scheme 8.
Scheme 8.
(A) Synthesis and (B) ring-opening of sulfamate epoxide substrates.
Scheme 9.
Scheme 9.
(A) Ring-opening of aziridines by pendant sulfamates. (B) Functionalization reactions of the products.
Scheme 10.
Scheme 10.
Synthesis of alkenyl silanols.
Scheme 11.
Scheme 11.
A remarkable cascade, likely triggered by adventitious TfOH.
Scheme 12.
Scheme 12.
1 equivalent of NaHCO3 stabilizes the dioxasilinane product.
Scheme 13.
Scheme 13.
Formal rearrangement of allylic silanols.
Scheme 14.
Scheme 14.
Dioxasilolanes and organomercury ketones from allylic silanols.
Scheme 15.
Scheme 15.
A tethered silanoxy-iodination reaction.
Scheme 16.
Scheme 16.
Silanoxyselenylation and hydroxyselenylation reactions.
Scheme 17.
Scheme 17.
Cleavage of epoxides with silanol tethers.
Scheme 18.
Scheme 18.
“Dancing” silanols.
Scheme 19.
Scheme 19.
A short preparation of muricatacin.
Scheme 20.
Scheme 20.
Ring opening of aziridines by pendant silanols allows for the preparation of sphingosine-type natural products.
Scheme 21.
Scheme 21.
Stereospecific preparation of 1’-amino-tetrahydrofurans.
Scheme 22.
Scheme 22.
Interception of palladium pi-allyl species by pendant silanols.

References

    1. Sathyamoorthi S, Banerjee S, Du Bois J, Burns NZ and Zare RN, Chem. Sci 2018, 9, 100–104. - PMC - PubMed
    1. Roizen JL, Harvey ME and Du Bois J, Acc. Chem. Res 2012, 45, 911–922; - PMC - PubMed
    2. b) Alderson JM, Corbin JR and Schomaker JM, Acc. Chem. Res 2017, 50, 2147–2158; - PubMed
    3. c) Ide T, Feng K, Dixon CF, Teng D, Clark JR, Han W, Wendell CI, Koch V. and White MC, J. Am. Chem. Soc 2021, 143, 14969–14975; - PMC - PubMed
    4. d) Kazerouni AM, McKoy QA and Blakey SB, Chem. Commun 2020, 56, 13287–13300; - PubMed
    5. e) Macklin TK and Snieckus V, Org. Lett 2005, 7, 2519–2522. - PubMed
    1. Espino CG, Wehn PM, Chow J. and Du Bois J, J. Am. Chem. Soc 2001, 123, 6935–6936.
    1. a) Wang D, Weinstein AB, White PB and Stahl SS, Chem. Rev 2018, 118, 2636–2679; - PubMed
    2. b) Kotov V, Scarborough CC and Stahl SS, Inorg. Chem 2007, 46, 1910–1923. - PubMed
    1. Hegedus LS, Allen GF, Bozell JJ and Waterman EL, J. Am. Chem. Soc 1978, 100, 5800–5807.

LinkOut - more resources